Event-Driven Stocks

Inari Medical, Inc.

NARI

Healthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs5 good3 warningdetails ↓

Financials

SEC XBRL · annual
 FY23FY22FY21FY20FY19FY18
Revenue$493.6M$383.5M$277.0M$139.7M$51.1M$6.8M
Operating income−$14.0M−$28.1M$10.8M$18.4M$801,000−$9.1M
Net income−$1.6M−$29.3M$9.8M$13.8M−$1.2M−$10.2M
Total assets$674.2M$504.2M$311.5M$214.1M$44.5M
Total liabilities$209.3M$87.2M$72.3M$13.8M$29.5M
Equity$464.9M$417.0M$239.2M$200.3M−$39.1M−$39.4M
EPS (diluted)$-0.03$-0.55$0.18$0.27$-0.20$-2.01
Shares out.54.3M50.6M49.5M49.3M6.7M5.1M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2023
Operating margin
−2.8%
Net margin
−0.3%
Return on equity
−0.4%
Return on assets
−0.2%
Return on capital (ROCE)
−2.3%
Liabilities / assets
31.0%
Debt / equity
0.45×
Book value / share
$8.56
Revenue growth (YoY)
28.7%
Net income growth (YoY)

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2023
Altman Z″ (distress)
3.51safe
Accruals / assets
5.6%clean
Beneish M-Score
-1.12elevated
Piotroski F-Score
4/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
67
/ 100
Profitability 0Growth 100Catalyst 33Earnings quality 100Financial strength 100

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

3 warning5 good
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Beneish M-Score elevated — earnings-manipulation screen flag
  • Revenue is growing year-over-year
  • Conservative leverage (liabilities < 50% of assets)
  • Positive operating cash flow
  • Clean earnings (low accruals)
  • Altman Z″ in the safe zone

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)